1. Volume 379, Issue 9812, Pages 221-228 (January 2012)
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial 
Prof Hoosen M Coovadia, MD, Elizabeth R Brown, ScD, Mary Glenn Fowler, Tsungai Chipato, MBChB, Dhayendre Moodley, PhD, Karim Manji, MBBS, Philippa Musoke, MBChB, Lynda Stranix-Chibanda, MBChB, Vani Chetty, BTech, Wafaie Fawzi, MD, Clemensia Nakabiito, MBChB, Lindiwe Msweli, BA, Roderick Kisenge, MMed, Laura Guay, MD, Anthony Mwatha, MS, Diana J Lynn, BA, Susan H Eshleman, MD, Paul Richardson, MSc, Kathleen George, MPH, Philip Andrew, RN, Lynne M Mofenson, MD, Sheryl Zwerski, CRNP, Yvonne Maldonado, MD 
The Lancet 
Volume 379, Issue 9812, Pages (January 2012)
DOI: /S (11)61653-X
Copyright © 2012 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
*Only main cause is listed. †Two first-born twins not eligible, one congenital heart defect, one mother in accident, two poor adherence to study procedures, and one mother could not dose competently.
The Lancet  , DOI: ( /S (11)61653-X)
Copyright © 2012 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan-Meier analysis of breastfeeding duration, by study group
The Lancet  , DOI: ( /S (11)61653-X)
Copyright © 2012 Elsevier Ltd Terms and Conditions

4. Figure 3
Kaplan-Meier analysis of cumulative rates of HIV-1 infection, by study group
The Lancet  , DOI: ( /S (11)61653-X)
Copyright © 2012 Elsevier Ltd Terms and Conditions